[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fo49ceDbichU0epESE-FlFlHyuqSevj0JubYAVF3MPGI":8,"$fNWwV6Ta5jPt7ulZAM2YqgpO10JW_eRabF5RsD1x_Bq4":55,"$f3E76_wPa3YIZpp4pvH6CWO9_GM-wniu-5W_PGZafVIg":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},51863,868812,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//zdvKwwpnMtYwusNReBVaFVjt4zA4Kj7D.png","蔡文","浙江大学医学院附属第二医院","肿瘤科","住院医师",28,0,"直肠癌术后肺转移治疗方案的用药实用指南","","https://ystcdn.venuertc.com/venue/AI/517ee9ec-7f8c-47c9-9da2-931332fc7d84.jpg","\u003Cdiv class=\"rectalcancer-guide-root\">\n  \u003Ch1 id=\"material_title\" class=\"rectalcancer-guide-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\n    直肠癌术后肺转移治疗方案的用药实用指南\n  \u003C/h1>\n\n  \u003Cdiv class=\"rectalcancer-guide-intro\">\n    说到直肠癌术后肺转移相关的用药方案，不少患者和家属都会关心化疗药、靶向药以及相关辅助用药的安全性和正确方法。这些药品类型多、用法各异，安全性和效果很大程度上取决于细节把控。本文将聚焦6个关键药品的实用用药细节，涵盖奥沙利铂、卡培他滨、贝伐珠单抗等常用方案，帮助您掌握放心用药的要点。\n  \u003C/div>\n\n  \u003C!-- 01 药品简介与剂型特点 -->\n  \u003Csection class=\"rectalcancer-guide-section rectalcancer-section-bg1\">\n    \u003Ch2 class=\"rectalcancer-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">01 奥沙利铂注射液：剂型特点与服用技巧\u003C/h2>\n    \u003Cp>\n      奥沙利铂（Oxaliplatin）是一种三价铂类化疗药，以注射液剂型应用最广，常用于冲洗后经静脉滴注。其规格多为50mg/瓶或100mg/瓶，使用时必须配合葡萄糖溶液稀释，不能用氯化钠溶液稀释，以免影响药效和稳定性。\u003Cbr>\n      \u003Cspan class=\"rectalcancer-guide-icon\">💡\u003C/span>正确做法：由专业人员按体表面积和方案设定，配置和输注奥沙利铂，输液过程中需缓慢滴注，一般不宜少于2小时。\n    \u003C/p>\n    \u003Cp>\n      服药技巧：\u003Cb>不自行调配/注射\u003C/b>，输液时保持手脚温暖，有助于减轻末梢麻木的感觉。遇到局部刺痛、灼热等不适应及时呼叫医生。\n    \u003C/p>\n  \u003C/section>\n\n  \u003C!-- 02 化疗药品用法用量 -->\n  \u003Csection class=\"rectalcancer-guide-section rectalcancer-section-bg2\">\n    \u003Ch2 class=\"rectalcancer-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">02 卡培他滨片：规范用法用量\u003C/h2>\n    \u003Cp>\n      卡培他滨（Capecitabine）属于口服氟嘧啶类药物，常见规格有0.5g/片，包装为盒装。此药通常需\u003Cb>餐后30分钟内用足量温水送服，切勿嚼碎\u003C/b>。每日分早晚2次，严格根据医嘱按体重、体表面积计算总剂量。\u003Cbr>\n      \u003Cspan class=\"rectalcancer-guide-icon\">📅\u003C/span>剂量举例：常见疗程为连续服用14天，停7天为一个周期。\n    \u003C/p>\n    \u003Cdiv class=\"rectalcancer-guide-tip\">\n      \u003Cb>特别提醒：\u003C/b> 忘记服药勿自行加量补服，下次定时服即可。如连续多次遗漏或出现呕吐/吐泻影响吸收，须及时联系医生调整方案。\n    \u003C/div>\n  \u003C/section>\n  \n  \u003C!-- 03 靶向药物关键点 -->\n  \u003Csection class=\"rectalcancer-guide-section rectalcancer-section-bg3\">\n    \u003Ch2 class=\"rectalcancer-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">03 贝伐珠单抗注射液：注意输注方式与风险\u003C/h2>\n    \u003Cp>\n      贝伐珠单抗（Bevacizumab）是靶向抗肿瘤血管生成的人源化单克隆抗体，多为100mg/4ml或400mg/16ml注射用浓溶液。使用前需稀释，\u003Cb>经静脉滴注缓慢输入\u003C/b>，首剂多需90分钟以上，后续可缩短至60分钟或更久。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>输注期间需密切观察过敏：出现打喷嚏、气促、面色变化应立刻停止用药。\u003C/li>\n      \u003Cli>不可与含葡萄糖溶液混合使用。\u003C/li>\n      \u003Cli>注射间隔应严格遵医嘱，通常每2周一次，也有3周一次的方案。\u003C/li>\n    \u003C/ul>\n    \u003Cdiv class=\"rectalcancer-guide-tip\">\n      医学研究显示，部分患者首剂输注发生反应的概率为 3%-10%\u003Csup>[1]\u003C/sup>。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 04 药物相互作用与不良反应 -->\n  \u003Csection class=\"rectalcancer-guide-section rectalcancer-section-bg4\">\n    \u003Ch2 class=\"rectalcancer-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">04 化疗与靶向药物的相互作用及风险点\u003C/h2>\n    \u003Cp>\n      奥沙利铂和卡培他滨常联合应用，二者在常规范围下相互作用风险较低，但\u003Cb>与3A级别以上肝酶诱导药、抗病毒药物等同用需谨慎\u003C/b>，可能影响药物清除和毒性。贝伐珠单抗联用其他化疗药时，注意药源性高血压、出血倾向及蛋白尿风险。\n    \u003C/p>\n    \u003Cul>\n      \u003Cli>服用华法林等抗凝药时，需更频繁监测凝血指标。\u003C/li>\n      \u003Cli>与含铂化疗药（如顺铂）合用时，易加重肾脏损伤风险。\u003C/li>\n      \u003Cli>不能自行加用草药、中成药，防止不明成分影响药效或增加副作用。\u003C/li>\n    \u003C/ul>\n    \u003Cp>\n      \u003Cb>正确做法：\u003C/b> 就诊时主动告知所有正在使用的药物，包括营养补充剂。\n    \u003C/p>\n  \u003C/section>\n\n  \u003C!-- 05 不良反应的识别与处理 -->\n  \u003Csection class=\"rectalcancer-guide-section rectalcancer-section-bg5\">\n    \u003Ch2 class=\"rectalcancer-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">05 常见不良反应与自我处理措施\u003C/h2>\n    \u003Cp>\n      涉及多种用药，常见不良反应各有侧重：\u003Cbr>\n      \u003Cspan class=\"rectalcancer-guide-listtitle\">奥沙利铂：\u003C/span> 主要为末梢麻木、咽喉痛、急性过敏反应。遇到\u003Cstrong>手脚发麻\u003C/strong>可暂时远离冷水。\u003Cbr>\n      \u003Cspan class=\"rectalcancer-guide-listtitle\">卡培他滨：\u003C/span> 可能发生口腔溃疡、手足红肿脱皮。发现\u003Cb>手足不适\u003C/b>及时保护双手双脚，轻症可外用凡士林缓解。\u003Cbr>\n      \u003Cspan class=\"rectalcancer-guide-listtitle\">贝伐珠单抗：\u003C/span> 有蛋白尿、高血压、鼻出血、肠道出血的风险。如出现\u003Cb>肉眼可见血尿或突发高血压\u003C/b>，不可自行处理，需立即就医。\u003Cbr>\n    \u003C/p>\n    \u003Cdiv class=\"rectalcancer-guide-tip\">\n      数据表明，奥沙利铂导致末梢神经不良反应发生率为60%左右，贝伐珠单抗相关高血压为10%-18%\u003Csup>[2]\u003C/sup>。\n    \u003C/div>\n    \u003Cp>\n      \u003Cb>出现较重反应（如持续呕吐、严重皮疹、呼吸困难等）必须第一时间就医。\u003C/b>\n    \u003C/p>\n  \u003C/section>\n\n  \u003C!-- 06 特殊人群用药调整 -->\n  \u003Csection class=\"rectalcancer-guide-section rectalcancer-section-bg6\">\n    \u003Ch2 class=\"rectalcancer-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">06 老年人、肾肝功能异常及其他特殊人群用药\u003C/h2>\n    \u003Cp>\n      对65岁以上的患者、肝肾功能异常或其他合并基础病者，药品使用需要特别留意：\u003Cbr>\n      \u003Cspan class=\"rectalcancer-guide-listtitle\">奥沙利铂：\u003C/span> 存在肾功能减退时剂量调整，禁止超剂量。\u003Cbr>\n      \u003Cspan class=\"rectalcancer-guide-listtitle\">卡培他滨：\u003C/span> 重度肝肾功能异常者禁用。轻中度肾功能减退者需下调剂量，每24小时尿量不足800ml时须报告医生。\u003Cbr>\n      \u003Cspan class=\"rectalcancer-guide-listtitle\">贝伐珠单抗：\u003C/span> 孕妇哺乳期禁用，高血压未控制、近期大手术或创伤患者慎用。\u003Cbr>\n    \u003C/p>\n    \u003Cdiv class=\"rectalcancer-guide-tip\">\n      案例举例：有位老年患者采用奥沙利铂治疗期间，经医生评估下调了剂量，有效减轻了神经不良反应。\n    \u003C/div>\n    \u003Cul>\n      \u003Cli>儿童需权衡风险，严格遵医生指引。\u003C/li>\n      \u003Cli>计划怀孕、哺乳的患者须提前停药并知会医师。\u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 07 药品储存及保存期限 -->\n  \u003Csection class=\"rectalcancer-guide-section rectalcancer-section-bg7\">\n    \u003Ch2 class=\"rectalcancer-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">07 储存条件和过期药品处理\u003C/h2>\n    \u003Cp>\n      \u003Cspan class=\"rectalcancer-guide-listtitle\">奥沙利铂注射液：\u003C/span> 药瓶未开封密封后，建议于2-8℃冷藏保存，避免阳光直射和剧烈晃动；配置好后的稀释液最迟24小时内用完。\u003Cbr>\n      \u003Cspan class=\"rectalcancer-guide-listtitle\">卡培他滨片：\u003C/span> 室温存放即可，需防潮防湿，避免儿童误拿。\u003Cbr>\n      \u003Cspan class=\"rectalcancer-guide-listtitle\">贝伐珠单抗注射液：\u003C/span> 必须2-8℃冷藏，稀释后建议4-6小时内使用完毕。\u003Cbr>\n      过期药品应放入有害垃圾回收通道，不可随意丢弃或自行处理。\n    \u003C/p>\n    \u003Cp>\n      \u003Cspan class=\"rectalcancer-guide-icon\">🕑\u003C/span> 正确做法：药品拆封后，请在包装上标记首用日期，并定期检查药品外观，发现浑浊、变色或沉淀请勿使用。\n    \u003C/p>\n  \u003C/section>\n\n  \u003C!-- 08 漏服与过量应对 -->\n  \u003Csection class=\"rectalcancer-guide-section rectalcancer-section-bg8\">\n    \u003Ch2 class=\"rectalcancer-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">08 漏服与过量用药时的应对关键\u003C/h2>\n    \u003Cp>\n      \u003Cspan class=\"rectalcancer-guide-listtitle\">卡培他滨漏服：\u003C/span> 如发现漏服，跳过该次，继续下次原定剂量。不要自行加倍补服。\u003Cbr>\n      \u003Cspan class=\"rectalcancer-guide-listtitle\">化疗药物过量：\u003C/span> 一旦误用大剂量或不慎多服，须立即前往医院抢救。不要等待症状出现后才处理。\u003Cbr>\n      \u003Cspan class=\"rectalcancer-guide-listtitle\">贝伐珠单抗等注射液：\u003C/span> 输注过程中如肢体麻木、高热、皮疹等急性反应，应立即报告医护人员，切勿坚持输液。\n    \u003C/p>\n    \u003Cp>\n      \u003Cb>特别提醒：\u003C/b> 化疗和靶向药均需设定安全剂量，无论是规律使用还是发生差错，都应及时与医生沟通，不要擅自调整。\n    \u003C/p>\n  \u003C/section>\n\n  \u003C!-- 09 临床用药案例分享 -->\n  \u003Csection class=\"rectalcancer-guide-section rectalcancer-section-bg9\">\n    \u003Ch2 class=\"rectalcancer-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">09 临床用药案例提示\u003C/h2>\n    \u003Cul>\n      \u003Cli>一名65岁男性在术后按方案多次接受奥沙利铂、卡培他滨及贝伐珠单抗治疗，经专业定期调整剂量，未见严重不良反应。\u003C/li>\n      \u003Cli>临床上有患者在服用卡培他滨期间自行加服多次，结果出现严重手足综合征。正确方法是如漏服不需补服，加量用药风险极大。\u003C/li>\n      \u003Cli>部分患者注射贝伐珠单抗后发生短暂高血压，经停药及对症处理后缓解，证明早识别和干预极为重要。\u003C/li>\n    \u003C/ul>\n  \u003C/section>\n\n  \u003C!-- 结尾 -->\n  \u003Csection class=\"rectalcancer-guide-conclusion\">\n    \u003Ch2 class=\"rectalcancer-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">结语：牢牢把控每一步，安全用药更有底气\u003C/h2>\n    \u003Cp>\n      奥沙利铂、卡培他滨和贝伐珠单抗等药品，在实际治疗直肠癌术后肺转移方案中扮演着重要角色。每一项细节都直接影响到用药的安全和效果。\u003Cbr>\n      请务必记住：\u003Cb>用药前后严格遵照医嘱，用药过程中密切关注反应，遇到异常及时就诊。\u003C/b>安全用药、定期复查，是每位患者和家属共同的责任。\u003Cbr>\n      只有守好药品使用的每一个环节，才能真正用药无忧。\n    \u003C/p>\n  \u003C/section>\n\n  \u003C!-- 参考文献 -->\n  \u003Csection class=\"rectalcancer-guide-section rectalcancer-section-bg-ref\">\n    \u003Ch2 class=\"rectalcancer-guide-h2\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">参考文献\u003C/h2>\n    \u003Col class=\"rectalcancer-guide-ref\">\n      \u003Cli>\n        Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer. \u003Ci>New England Journal of Medicine\u003C/i>, 2004, 350(23): 2335-2342.\n      \u003C/li>\n      \u003Cli>\n        Cassidy J, Clarke S, Díaz-Rubio E, et al. Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer. \u003Ci>Journal of Clinical Oncology\u003C/i>, 2008, 26(12): 2006–2012.\n      \u003C/li>\n      \u003Cli>\n        Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. \u003Ci>New England Journal of Medicine\u003C/i>, 2005, 352(5): 476-487.\n      \u003C/li>\n    \u003C/ol>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.rectalcancer-guide-root {\n  max-width: 980px;\n  margin: 36px auto;\n  background: #fff;\n  border-radius: 16px;\n  border: 1px solid #e6e6e6;\n  font-family: 'Helvetica Neue', 'Segoe UI', Arial, 'PingFang SC', 'Hiragino Sans GB', sans-serif;\n  line-height: 1.85;\n  box-shadow: 0 4px 28px rgba(60,90,120,0.09);\n  padding: 16px 26px 48px 26px;\n  color: #353535;\n}\n\n.rectalcancer-guide-title {\n  font-size: 2.1em;\n  font-weight: 700;\n  color: #244062;\n  letter-spacing: 0.04em;\n  text-align: center;\n  margin: 38px 0 20px 0;\n}\n\n.rectalcancer-guide-intro {\n  font-size: 1.14em;\n  margin: 0 0 36px 0;\n  padding: 20px 26px;\n  background: linear-gradient(90deg, #f6faff 60%, #eef1f6 100%);\n  border-radius: 12px;\n  color: #2a3853;\n  letter-spacing: 0.02em;\n}\n\n.rectalcancer-guide-section {\n  margin-bottom: 35px;\n  border-radius: 14px;\n  padding: 26px 24px 18px 24px;\n  box-shadow: 0 2px 10px 0 rgba(231,236,245,0.11);\n}\n\n.rectalcancer-section-bg1 {\n  background: linear-gradient(91deg, rgb(248, 252, 252) 60%, rgba(232, 238, 255, 0.14) 120%);\n}\n.rectalcancer-section-bg2 {\n  background: linear-gradient(96deg, #f7f6ff 70%, #e7f4f7 130%);\n}\n.rectalcancer-section-bg3 {\n  background: linear-gradient(80deg, #f3f8fa 44%, #e6f2f7 130%);\n}\n.rectalcancer-section-bg4 {\n  background: linear-gradient(110deg, #f3f7f7 60%, #f5e8ee 128%);\n}\n.rectalcancer-section-bg5 {\n  background: linear-gradient(92deg, #faf9f6 71%, #eaf0ee 120%);\n}\n.rectalcancer-section-bg6 {\n  background: linear-gradient(89deg, #f2faf7 60%, #e4efff 140%);\n}\n.rectalcancer-section-bg7 {\n  background: linear-gradient(100deg, #f9faf9 60%, #e7f4f7 130%);\n}\n.rectalcancer-section-bg8 {\n  background: linear-gradient(85deg, #fdfcff 62%, #e7eefa 140%);\n}\n.rectalcancer-section-bg9 {\n  background: linear-gradient(93deg, #f9fcfd 44%, #e6f2f7 140%);\n}\n.rectalcancer-section-bg-ref {\n  background: linear-gradient(101deg, #eceef4 88%, #f2fafd 120%);\n  padding: 20px 16px;\n}\n\n.rectalcancer-guide-h2 {\n  font-size: 1.3em;\n  font-weight: 600;\n  color: #236093;\n  margin: 0 0 15px 0;\n  letter-spacing: 0.02em;\n  border-left: 5px solid #87b5dd;\n  padding-left: 12px;\n  background: none;\n  line-height: 1.35;\n}\n\n.rectalcancer-guide-tip {\n  margin: 16px 0 0 0;\n  background: #f9f3e7;\n  color: #845614;\n  border-radius: 7px;\n  font-size: 1em;\n  padding: 13px 16px;\n  box-sizing: border-box;\n  line-height: 1.6;\n}\n\n.rectalcancer-guide-listtitle {\n  color: #30869c;\n  font-weight: 600;\n}\n\n.rectalcancer-guide-icon {\n  margin-right: 6px;\n  font-size: 1.05em;\n}\n\n.rectalcancer-guide-ref {\n  padding-left: 18px;\n  font-size: 1em;\n  color: #3a4752;\n}\n\n.rectalcancer-guide-conclusion {\n  background: linear-gradient(91deg,#f8fafd 70%,#eef2f6 130%);\n  border-radius: 13px;\n  font-size: 1.16em;\n  text-align: left;\n  margin:36px 0 25px 0;\n  padding: 24px 26px 22px 26px;\n  color: #23507c;\n  letter-spacing: 0.01em;\n}\n\n@media (max-width: 700px) {\n  .rectalcancer-guide-root {\n    padding: 6px 2% 32px 2%;\n    max-width: 98vw;\n  }\n  .rectalcancer-guide-section {\n    padding: 17px 7px 9px 11px;\n  }\n  .rectalcancer-guide-intro, .rectalcancer-guide-conclusion {\n    padding: 14px 8px;\n  }\n}\n\u003C/style>\n","\u003Cdiv class=\"rectalcancer-guide-root\">\n  \u003Ch1 id=\"material_title\" class=\"rectalcancer-guide-title\" sty",523,"2025-07-24 10:03:54","直肠癌, 肺转移, 奥沙利铂, 卡培他滨, 贝伐珠单抗, 化疗, 靶向治疗, 用药指南","本指南为直肠癌术后肺转移患者提供安全有效的用药方案，涵盖奥沙利铂、卡培他滨、贝伐珠单抗等药物，确保患者用药成功与安全。","2025-08-07 06:18:00",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]